Literature DB >> 2626364

Volume corrected mitotic index (M/V-INDEX). The standard of mitotic activity in neoplasms.

H Haapasalo1, E Pesonen, Y Collan.   

Abstract

Estimation of mitotic activity by counting the number of mitotic figures per high power fields is subject to many sources of error. The microscope fields vary in size in different microscopes, which makes comparisons arbitrary. Also the areas covered by neoplastic and non-neoplastic tissue in the microscope image vary in different tumors. We found that each microscope could easily be characterized in terms of the size of the microscope field at 40x objective magnification (usually at ocular magnification of 10x). We also found that the number of mitotic figures can be related to the area covered by neoplastic tissue in the microscope field. The resulting index, the volume corrected mitotic index (M/V-index) will express the mitotic activity as the number of mitotic figures per square millimeter of neoplastic tissue in the microscope fields. The M/V-index will not be subject to the variation in volume fractions of neoplastic tissue between different neoplasms. With the M/V-index the mitotic activity as measured in different microscopes can be compared reliably. The value of the method is demonstrated in a series of ovarian tumors.

Entities:  

Mesh:

Year:  1989        PMID: 2626364     DOI: 10.1016/S0344-0338(89)80191-8

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  20 in total

Review 1.  Proliferation markers in tumours: interpretation and clinical value.

Authors:  P J van Diest; G Brugal; J P Baak
Journal:  J Clin Pathol       Date:  1998-10       Impact factor: 3.411

2.  A quantitative method for the assessment of intraepidermal nerve fibers in small-fiber neuropathy.

Authors:  Mika Koskinen; Aki Hietaharju; Maarit Kyläniemi; Jukka Peltola; Immo Rantala; Bjarne Udd; Hannu Haapasalo
Journal:  J Neurol       Date:  2005-03-29       Impact factor: 4.849

3.  Mitotic indexes as prognostic predictors in female breast cancer.

Authors:  S Aaltomaa; P Lipponen; M Eskelinen; V M Kosma; S Marin; E Alhava; K Syrjänen
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

4.  Expression of MIB-1, mitotic index and S-phase fraction as indicators of cell proliferation in superficial bladder cancer. Finnbladder Group.

Authors:  T J Liukkonen; P K Lipponen; M Helle; H K Haapasalo; S Nordling; P Rajala
Journal:  Urol Res       Date:  1996

5.  The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus.

Authors:  G O Elpek; T Gelen; N H Aksoy; A Erdoğan; L Dertsiz; A Demircan; N Keleş
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

6.  Downregulation of p21/WAF1 is related to advanced and dedifferentiated laryngeal squamous cell carcinoma.

Authors:  P Hirvikoski; J K Kellokoski; E J Kumpulainen; J A Virtaniemi; R T Johansson; V M Kosma
Journal:  J Clin Pathol       Date:  1999-06       Impact factor: 3.411

7.  The prognostic value of basement membrane morphology, tumour histology and morphometry in superficial bladder cancer.

Authors:  P K Lipponen
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

8.  Structural examination of tryptase- and chymase-positive mast cells in livers, containing metastases from gastrointestinal cancers.

Authors:  Maya Vladova Gulubova
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

9.  The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time.

Authors:  R Schröder; K Bien; R Kott; I Meyers; R Vössing
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

10.  Evaluating the response to antioestrogen toremifene treatment in DMBA induced rat mammary carcinoma.

Authors:  R Huovinen; P L Kellokumpu-Lehtinen; Y Collan
Journal:  Int J Exp Pathol       Date:  1994-08       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.